Le diagnostic photodynamique (cystoscopie avec hexaminolévulinate) dans la surveillance des lesions urothéliales traitées de façon conservative

Annales de Pathologie

Volumn 30, Issue 5 SUPPL.1, 2010, Pages 115-116

  Vordos, Dimitri ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5-AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; DIAGNOSTIC AGENT; DRUG DERIVATIVE;

ARTICLE; BLADDER TUMOR; CYSTOSCOPY; HUMAN;

AMINOLEVULINIC ACID; CYSTOSCOPY; HUMANS; URINARY BLADDER NEOPLASMS;

EID: 79953731780     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annpat.2010.07.020     Document Type: Conference Paper

References (4)

1. Jocham D., Stepp H., Waidelich R. Photodynamic diagnosis in urology: state-of-the-art. Eur Urol 2008, 53:1138-1148.
2. Marti A., Jichlinski P., Lange N., Ballini J.P., Guillou L., Leisinger H.J., et al. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. J Urol 2003, 170:428-432.
3. Denzinger S., Burger M., Walter B. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Urology 2007, 69:675-679.
4. ®) et du diagnostic photodynamique. Progr Urol FMC 2009, 19:9-14.